Threepoint Therapeutics ApS
CVR 46754565 · Private limited company (ApS) · Active · Medium risk
Threepoint Therapeutics ApS is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.3% over the next 12 months, which is 1.6 times the average for Danish companies.
Bankruptcy risk for Threepoint Therapeutics ApS
1.6 × the average (1.41%) · higher risk than 84% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 46754565
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (0 years)
- Address
- Venlighedsvej 4
2970 Hørsholm - Municipality
- Rudersdal
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 20k
- Auditor
- PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 0 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 8 |
| Going-concern uncertainty | No |
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Thomas Nikolaj Sager | Current | |
| Board | Mahmoud Mahmoudian | Current | |
| Board | Mi Chung Ahn | Current | |
| Board | Jaeyoung Lee | Current | |
| Board | Woohyun Lee | Current | |
| Owner (100%) | Bukwang Pharmaceutical Co., Ltd | Current | |
| Auditor | PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab | Current |
Address history (0 moves)
| Venlighedsvej 4, 2970 Hørsholm |
Other companies at the same address
- CONTERA PHARMA A/S Active
- CUTISENSE A/S Opløst
- DELTA CARE A/S Opløst
- DELTA NEW-BIZZ A/S Opløst
- DELTA READER A/S Opløst
- DRALLE A/S Active
- ICTALCARE A/S Active
- Presto Engineering Denmark ApS Active
Similar companies in Rudersdal
- Zaphe ApS Hørsholm
- Floratinia ApS Holte
- Dirac Drives ApS Hørsholm
- Johnsen Bioconsult ApS Skodsborg
- Dantefusion ApS Birkerød
- Typo foods ApS Vedbæk
- Pexinno ApS Holte
- Cerdes Science ApS Birkerød
- Pedersen Scientific ApS Birkerød
- NaviSurg Vision ApS Holte
- Fluispotter ApS Vedbæk
- Tier One Nordic ApS Holte
Questions and answers about Threepoint Therapeutics ApS
Has Threepoint Therapeutics ApS gone bankrupt?
No, Threepoint Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Threepoint Therapeutics ApS?
Our model estimates a bankruptcy risk of 2.3% over the next 12 months (medium risk), which is 1.6 times the average for Danish companies.
Who is the auditor of Threepoint Therapeutics ApS?
Threepoint Therapeutics ApS most recently used PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab.
When was Threepoint Therapeutics ApS founded?
Threepoint Therapeutics ApS was founded on 25 August 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.